RIGEL PHARMACEUTICALS, INC. Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss
RIGEL PHARMACEUTICALS, INC. (RIGL) had Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss of $148.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Debt and Equity Securities
us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss · last filed 2026-08-04
- 2026-06-30: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss $148.00K.
- 2026-03-31: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss $170.00K.
- 2025-12-31: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss $3.00K.
- 2025-09-30: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss $11.00K.
| Period end | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss |
|---|---|
| 2026-06-30 | $148.00K 10-Q · filed 2026-08-04 |
| 2026-03-31 | $170.00K 10-Q · filed 2026-05-05 |
| 2025-12-31 | $3.00K 10-K · filed 2026-03-03 |
| 2025-09-30 | $11.00K 10-Q · filed 2025-11-04 |
| 2025-06-30 | $13.00K 10-Q · filed 2025-08-05 |
| 2025-03-31 | $7.00K 10-Q · filed 2025-05-06 |
| 2024-06-30 | $9.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $8.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $7.00K 10-K · filed 2024-03-05 |
| 2023-09-30 | $18.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $29.00K 10-Q · filed 2023-08-01 |
| 2023-03-31 | $32.00K 10-Q · filed 2023-05-02 |
| 2022-12-31 | $154.00K 10-K · filed 2023-03-07 |
| 2022-09-30 | $290.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $438.00K 10-Q · filed 2022-08-02 |
| 2022-03-31 | $416.00K 10-Q · filed 2022-05-03 |
| 2021-12-31 | $104.00K 10-K · filed 2022-03-01 |
| 2021-09-30 | $7.00K 10-Q · filed 2021-11-02 |
| 2020-12-31 | $4.00K 10-K · filed 2021-03-02 |
| 2020-09-30 | $1.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $2.00K 10-Q · filed 2020-08-04 |
| 2020-03-31 | $9.00K 10-Q · filed 2020-05-05 |
| 2019-12-31 | $7.00K 10-K · filed 2020-02-27 |
| 2019-09-30 | $3.00K 10-Q · filed 2019-11-05 |
| 2019-06-30 | $8.00K 10-Q · filed 2019-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |